Q5144 Injection, idacio, 1 milligrams
Also known as: adalimumab biosimilar, Idacio
Injection of adalimumab-idacio (Idacio), a biosimilar to adalimumab, administered at 1 milligram per dose.
In Plain Language
TNF blocker injection; arthritis medication; immune system blocker
Clinical Context
Used for treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease. Administered subcutaneously every 2 weeks as maintenance therapy.
RVU Information
CPT Q5144 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5144?
CPT Q5144 (Injection, idacio, 1 milligrams) is a Q Codes code. Injection of adalimumab-idacio (Idacio), a biosimilar to adalimumab, administered at 1 milligram per dose.
Is Q5144 covered by insurance?
Q5144 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease. Administered subcutaneously every 2 weeks as maintenance therapy.
When is CPT Q5144 used?
Used for treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease. Administered subcutaneously every 2 weeks as maintenance therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.